Patients can minimize winter slip-and-fall injuries through proactive measures like wearing proper footwear and clearing ...
Summary: Out-of-pocket costs for branded drugs for neurological diseases, particularly for multiple sclerosis (MS), have ...
Luna, provider of in-home, outpatient physical therapy (PT), has partnered with Duke Health to broaden access to PT services ...
A study co-led by UCLA and Baylor College of Medicine evaluated whether wearable TENS devices may help alleviate pain and ...
New research highlights how brain interference in muscle activation contributes to challenges in rehab for people with hip ...
Nervonik, a medical device startup, successfully completed its first-in-human clinical study for a novel peripheral nerve stimulation (PNS) device aimed at treating chronic pain, demonstrating safety, ...
Cerevance has initiated the Phase 3 ARISE trial to evaluate solengepras, a non-dopaminergic therapy targeting specific brain circuits, as a potential adjunctive treatment for Parkinson’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback